← Analysis page  ·  Pieter Slegers hub  ·  Research hub

Actionable insights — Brookfield Deep Dive, Part 1

Not whether to buy Brookfield, but how to analyse a company whose reported financials don't describe it — and how to pick the right ticker out of a family of listings.
2025-DEC-11 · Compounding Quality (Substack) · guest analyst Jochen Vandenbergh · read ↗ · full analysis · transcript
How to read this page: each insight is a method used in the post — a way of handling a company that standard metrics misdescribe. Written post, so no timestamps.

1. Before measuring anything, ask whether the standard metric even applies

The repeatable method
  1. For each metric you habitually use (revenue, gross margin, ROIC), ask what it assumes about the business — a product sold at a markup, an identifiable pool of invested capital.
  2. Where consolidation rules force a company to report 100% of a partly-owned asset's revenue, or where the profitable segment barely produces revenue at all, discard the metric rather than adjusting it.
  3. Replace it with the measure management itself steers by — then verify that measure is honest by checking how it behaves across a full cycle.
Here: BN books all the revenue of assets it owns 30–60% of, and almost none from the fee businesses that generate most of the profit — so revenue is "not a reliable measure," and Distributable Earnings replaces it.
Watch for

2. Read a capital-recycling business through the cycle, not the year

The repeatable method
  1. Identify whether the company's model is invest → improve → sell → reinvest. If so, expect revenue and cash flow to move in opposite directions at different points of the loop.
  2. When revenue rises and cash earnings fall, check whether it is buying and building; when revenue falls and cash earnings jump, check whether it is harvesting mature assets.
  3. Judge progress on the through-cycle trend of the cash metric and on value per share, not on annual revenue growth.
Here: 2022–23 revenue up while DE fell, then the reverse — "just the recycling cycle at work." DE compounded at 10%/yr regardless; DE before realizations at 20%.
Watch for

3. Separate the recurring core from the lumpy gains

The repeatable method
  1. Split the headline cash metric into the part that recurs (fees, contracted cash flows, spread income) and the part that depends on transactions (realized gains, carried interest).
  2. Track the recurring line as the real growth rate of the business; treat the transactional line as timing.
  3. Check each division contributes — a single segment carrying the growth is a concentration risk hidden inside a diversified label.
Here: "DE before realizations" is singled out as the better number — 20% CAGR over five years, +21% at the Sept 2025 Investor Day, "with each core business contributing… no weak links."
Watch for

4. In a family of listed entities, decide deliberately which claim you are buying

The repeatable method
  1. Map the group: list every listed entity, what it holds, and the parent's ownership percentage of each.
  2. Decide whether you want the diversified claim (the parent, which owns stakes in all of them plus its own balance sheet) or a concentrated one (a single subsidiary's sector).
  3. Price the trade-off explicitly: the subsidiary offers purity and sector risk; the parent offers the mix and a holding-company discount.
Here: six tickers — BN (parent) plus BAM ~73%, BNT (100% of Class C), BEP ~60%, BIP ~30%, BBU ~90% with affiliates. "Buying BN gives you the mix. Buying the subsidiaries gives you more focus but also more sector risk."
Watch for

5. Map the flywheel — ask what each division does for the others

The repeatable method
  1. Draw the loop rather than listing segments: what does owning the assets buy you in the fundraising business, and what does the fundraising business fund?
  2. Test whether the connection is real by asking whether removing one division would damage the others — if not, it is a conglomerate, not an ecosystem.
  3. Look for evidence of alignment that makes the loop self-reinforcing, such as co-investing the company's own capital alongside clients'.
Here: Operating Businesses prove operational expertise → Asset Management converts that credibility into $1trn+ of client capital and fees → Wealth Solutions adds permanent insurance float that flows back through the same platform, with $180bn of Brookfield's own perpetual capital invested beside clients.
Watch for

6. Measure skin in the game against salary, not in dollars

The repeatable method
  1. Convert insider ownership into a ratio of stock value to annual cash compensation — that ratio, not the dollar amount, shows where the executive's wealth actually comes from.
  2. Check the aggregate too: what percentage of the company the key leaders hold together.
  3. Note the form of the holdings (options, escrowed shares, DSUs with different vesting) and avoid assigning one blended value to them.
Here: Bruce Flatt holds shares worth "roughly 8,000 times his annual salary," and the four key leaders together own 9% of a company worth hundreds of billions.
Watch for

7. Stage the work and withhold the verdict until the valuation step

The repeatable method
  1. Publish (or write) the analysis in a fixed order: business model → industry and risks → capital allocation and profitability → growth and valuation → decision.
  2. Score each stage as you go, but refuse to state a buy/sell until the valuation stage is done — so an impressive business cannot pre-commit you at any price.
  3. Keep the running scores visible, so the eventual decision can be traced back to which stage carried it.
Here: parts 1–2 award 8–9/10 across business model, management, moat, industry, risks and balance sheet, and still the explicit plan is "Part 5: put everything together and decide if we're buying the company or not."
Watch for

Methods distilled from the archived Compounding Quality post for personal study. Not investment advice.